Annual EBIT
-$439.59 M
-$190.46 M-76.45%
31 December 2023
Summary:
Revolution Medicines annual earnings before interest & taxes is currently -$439.59 million, with the most recent change of -$190.46 million (-76.45%) on 31 December 2023. During the last 3 years, it has fallen by -$331.13 million (-305.30%). RVMD annual EBIT is now -1316.93% below its all-time high of -$29.84 million.RVMD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$175.71 M
-$19.07 M-12.17%
30 September 2024
Summary:
Revolution Medicines quarterly earnings before interest & taxes is currently -$175.71 million, with the most recent change of -$19.07 million (-12.17%) on 30 September 2024. Over the past year, it has dropped by -$52.46 million (-42.57%). RVMD quarterly EBIT is now -1641.27% below its all-time high of -$10.09 million, reached on 30 June 2019.RVMD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$605.60 M
-$52.46 M-9.48%
30 September 2024
Summary:
Revolution Medicines TTM earnings before interest & taxes is currently -$605.60 million, with the most recent change of -$52.46 million (-9.48%) on 30 September 2024. Over the past year, it has dropped by -$245.84 million (-68.34%). RVMD TTM EBIT is now -5256.45% below its all-time high of -$11.31 million, reached on 31 December 2018.RVMD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVMD EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.5% | -42.6% | -68.3% |
| 3 y3 years | -305.3% | -231.9% | -260.0% |
| 5 y5 years | -954.9% | -1273.5% | -1267.3% |
RVMD EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -305.3% | at low | -234.3% | at low | -260.0% | at low |
| 5 y | 5 years | -954.9% | at low | -1273.5% | at low | -1267.3% | at low |
| alltime | all time | -1316.9% | at low | -1641.3% | at low | -5256.4% | at low |
Revolution Medicines EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$175.71 M(+12.2%) | -$605.60 M(+9.5%) |
| June 2024 | - | -$156.64 M(+11.2%) | -$553.14 M(+9.5%) |
| Mar 2024 | - | -$140.86 M(+6.4%) | -$505.29 M(+14.9%) |
| Dec 2023 | -$439.59 M(+76.5%) | -$132.39 M(+7.4%) | -$439.59 M(+22.2%) |
| Sept 2023 | - | -$123.25 M(+13.3%) | -$359.75 M(+14.9%) |
| June 2023 | - | -$108.80 M(+44.8%) | -$313.04 M(+17.5%) |
| Mar 2023 | - | -$75.16 M(+43.0%) | -$266.33 M(+6.9%) |
| Dec 2022 | -$249.13 M(+33.2%) | -$52.55 M(-31.3%) | -$249.12 M(-0.0%) |
| Sept 2022 | - | -$76.53 M(+23.3%) | -$249.25 M(+10.5%) |
| June 2022 | - | -$62.09 M(+7.1%) | -$225.65 M(+8.6%) |
| Mar 2022 | - | -$57.95 M(+10.0%) | -$207.86 M(+11.1%) |
| Dec 2021 | -$187.08 M | -$52.68 M(-0.5%) | -$187.08 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$52.94 M(+19.5%) | -$168.23 M(+18.1%) |
| June 2021 | - | -$44.30 M(+19.2%) | -$142.50 M(+13.6%) |
| Mar 2021 | - | -$37.16 M(+9.9%) | -$125.45 M(+15.7%) |
| Dec 2020 | -$108.46 M(+108.9%) | -$33.83 M(+24.3%) | -$108.46 M(+15.9%) |
| Sept 2020 | - | -$27.20 M(-0.2%) | -$93.58 M(+18.2%) |
| June 2020 | - | -$27.25 M(+35.1%) | -$79.17 M(+27.7%) |
| Mar 2020 | - | -$20.17 M(+6.5%) | -$62.00 M(+19.4%) |
| Dec 2019 | -$51.93 M(+24.6%) | -$18.95 M(+48.1%) | -$51.93 M(+17.2%) |
| Sept 2019 | - | -$12.79 M(+26.8%) | -$44.29 M(+40.6%) |
| June 2019 | - | -$10.09 M(-0.1%) | -$31.50 M(+47.1%) |
| Mar 2019 | - | -$10.10 M(-10.7%) | -$21.41 M(+89.3%) |
| Dec 2018 | -$41.67 M(+34.3%) | -$11.31 M | -$11.31 M |
| Dec 2017 | -$31.02 M | - | - |
FAQ
- What is Revolution Medicines annual earnings before interest & taxes?
- What is the all time high annual EBIT for Revolution Medicines?
- What is Revolution Medicines annual EBIT year-on-year change?
- What is Revolution Medicines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Revolution Medicines?
- What is Revolution Medicines quarterly EBIT year-on-year change?
- What is Revolution Medicines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Revolution Medicines?
- What is Revolution Medicines TTM EBIT year-on-year change?
What is Revolution Medicines annual earnings before interest & taxes?
The current annual EBIT of RVMD is -$439.59 M
What is the all time high annual EBIT for Revolution Medicines?
Revolution Medicines all-time high annual earnings before interest & taxes is -$29.84 M
What is Revolution Medicines annual EBIT year-on-year change?
Over the past year, RVMD annual earnings before interest & taxes has changed by -$190.46 M (-76.45%)
What is Revolution Medicines quarterly earnings before interest & taxes?
The current quarterly EBIT of RVMD is -$175.71 M
What is the all time high quarterly EBIT for Revolution Medicines?
Revolution Medicines all-time high quarterly earnings before interest & taxes is -$10.09 M
What is Revolution Medicines quarterly EBIT year-on-year change?
Over the past year, RVMD quarterly earnings before interest & taxes has changed by -$52.46 M (-42.57%)
What is Revolution Medicines TTM earnings before interest & taxes?
The current TTM EBIT of RVMD is -$605.60 M
What is the all time high TTM EBIT for Revolution Medicines?
Revolution Medicines all-time high TTM earnings before interest & taxes is -$11.31 M
What is Revolution Medicines TTM EBIT year-on-year change?
Over the past year, RVMD TTM earnings before interest & taxes has changed by -$245.84 M (-68.34%)